MX336736B - Composiciones de derivados de quitina parcialmente desacetilados. - Google Patents
Composiciones de derivados de quitina parcialmente desacetilados.Info
- Publication number
- MX336736B MX336736B MX2007015767A MX2007015767A MX336736B MX 336736 B MX336736 B MX 336736B MX 2007015767 A MX2007015767 A MX 2007015767A MX 2007015767 A MX2007015767 A MX 2007015767A MX 336736 B MX336736 B MX 336736B
- Authority
- MX
- Mexico
- Prior art keywords
- compositions
- deacetylated chitin
- partially deacetylated
- present
- processes
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08B—POLYSACCHARIDES; DERIVATIVES THEREOF
- C08B37/00—Preparation of polysaccharides not provided for in groups C08B1/00 - C08B35/00; Derivatives thereof
- C08B37/0006—Homoglycans, i.e. polysaccharides having a main chain consisting of one single sugar, e.g. colominic acid
- C08B37/0024—Homoglycans, i.e. polysaccharides having a main chain consisting of one single sugar, e.g. colominic acid beta-D-Glucans; (beta-1,3)-D-Glucans, e.g. paramylon, coriolan, sclerotan, pachyman, callose, scleroglucan, schizophyllan, laminaran, lentinan or curdlan; (beta-1,6)-D-Glucans, e.g. pustulan; (beta-1,4)-D-Glucans; (beta-1,3)(beta-1,4)-D-Glucans, e.g. lichenan; Derivatives thereof
- C08B37/0027—2-Acetamido-2-deoxy-beta-glucans; Derivatives thereof
- C08B37/003—Chitin, i.e. 2-acetamido-2-deoxy-(beta-1,4)-D-glucan or N-acetyl-beta-1,4-D-glucosamine; Chitosan, i.e. deacetylated product of chitin or (beta-1,4)-D-glucosamine; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7008—Compounds having an amino group directly attached to a carbon atom of the saccharide radical, e.g. D-galactosamine, ranimustine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
- A61K31/716—Glucans
- A61K31/722—Chitin, chitosan
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L24/00—Surgical adhesives or cements; Adhesives for colostomy devices
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L24/00—Surgical adhesives or cements; Adhesives for colostomy devices
- A61L24/04—Surgical adhesives or cements; Adhesives for colostomy devices containing macromolecular materials
- A61L24/08—Polysaccharides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L26/00—Chemical aspects of, or use of materials for, wound dressings or bandages in liquid, gel or powder form
- A61L26/0009—Chemical aspects of, or use of materials for, wound dressings or bandages in liquid, gel or powder form containing macromolecular materials
- A61L26/0023—Polysaccharides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L26/00—Chemical aspects of, or use of materials for, wound dressings or bandages in liquid, gel or powder form
- A61L26/0009—Chemical aspects of, or use of materials for, wound dressings or bandages in liquid, gel or powder form containing macromolecular materials
- A61L26/0028—Polypeptides; Proteins; Degradation products thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L26/00—Chemical aspects of, or use of materials for, wound dressings or bandages in liquid, gel or powder form
- A61L26/0061—Use of materials characterised by their function or physical properties
- A61L26/0066—Medicaments; Biocides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L26/00—Chemical aspects of, or use of materials for, wound dressings or bandages in liquid, gel or powder form
- A61L26/0061—Use of materials characterised by their function or physical properties
- A61L26/009—Materials resorbable by the body
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
- A61L27/14—Macromolecular materials
- A61L27/20—Polysaccharides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
- A61L27/50—Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials
- A61L27/54—Biologically active materials, e.g. therapeutic substances
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
- A61L27/50—Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials
- A61L27/58—Materials at least partially resorbable by the body
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08B—POLYSACCHARIDES; DERIVATIVES THEREOF
- C08B37/00—Preparation of polysaccharides not provided for in groups C08B1/00 - C08B35/00; Derivatives thereof
- C08B37/0003—General processes for their isolation or fractionation, e.g. purification or extraction from biomass
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
- C12P19/00—Preparation of compounds containing saccharide radicals
- C12P19/26—Preparation of nitrogen-containing carbohydrates
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Organic Chemistry (AREA)
- Molecular Biology (AREA)
- Materials Engineering (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pharmacology & Pharmacy (AREA)
- Dermatology (AREA)
- Oral & Maxillofacial Surgery (AREA)
- Transplantation (AREA)
- General Chemical & Material Sciences (AREA)
- Biochemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Polymers & Plastics (AREA)
- Wood Science & Technology (AREA)
- Zoology (AREA)
- Physical Education & Sports Medicine (AREA)
- Surgery (AREA)
- Rheumatology (AREA)
- Biomedical Technology (AREA)
- General Engineering & Computer Science (AREA)
- Genetics & Genomics (AREA)
- Biotechnology (AREA)
- Microbiology (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Immunology (AREA)
- Pain & Pain Management (AREA)
- Sustainable Development (AREA)
- Polysaccharides And Polysaccharide Derivatives (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Materials For Medical Uses (AREA)
Abstract
La presente invención se relaciona con composiciones que comprenden oligómeros quitinosos biológicamente activos y su endotoxina purificada y precursores poliméricos de quitina parcialmente desacetilados, y su uso en composiciones farmacéuticas, composiciones de biomaterial, dispositivos médicos, y procesos para producir los oligómeros. De manera más específica la presente invención se relaciona con composiciones y procesos novedosos para producir esas composiciones. Las composiciones incluyen composiciones heteropoliméricas y heterooligoméricas terapéuticas que comprenden secuencias específicas de N-acetil glucosamina y glucosamina, desarrolladas para optimizar las características químicas y estructurales que son importante para la actividad terapéutica de esas composiciones. Además, la presente invención proporciona métodos para usar un grado de desacetilación de un polímero de quitina parcialmente desacetilado para modular los parámetros físicos y biológicos en un compuesto de fosfato de calcio para aplicaciones en implantes óseos.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
IS7895 | 2005-06-14 | ||
PCT/IS2006/000013 WO2006134614A1 (en) | 2005-06-14 | 2006-06-14 | Compositions of partially deacetylated chitin derivatives |
Publications (1)
Publication Number | Publication Date |
---|---|
MX336736B true MX336736B (es) | 2016-01-29 |
Family
ID=36685789
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
MX2007015767A MX336736B (es) | 2005-06-14 | 2006-06-14 | Composiciones de derivados de quitina parcialmente desacetilados. |
Country Status (17)
Country | Link |
---|---|
US (3) | US9078949B2 (es) |
EP (1) | EP1917218B1 (es) |
JP (2) | JP5632125B2 (es) |
KR (1) | KR101569751B1 (es) |
CN (1) | CN101248019B (es) |
AU (1) | AU2006257177A1 (es) |
BR (1) | BRPI0612034A2 (es) |
CA (1) | CA2611453C (es) |
DK (1) | DK1917218T3 (es) |
HU (1) | HUE035956T2 (es) |
LT (1) | LT1917218T (es) |
MX (1) | MX336736B (es) |
NO (2) | NO344086B1 (es) |
NZ (1) | NZ565022A (es) |
RU (1) | RU2421467C2 (es) |
SI (1) | SI1917218T1 (es) |
WO (1) | WO2006134614A1 (es) |
Families Citing this family (28)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
IS6085A (is) * | 2001-09-26 | 2003-03-27 | Genis Ehf. | Lyfjablanda með kítósan óligómerum |
US9034348B2 (en) | 2006-12-11 | 2015-05-19 | Chi2Gel Ltd. | Injectable chitosan mixtures forming hydrogels |
EP1958639A1 (en) | 2007-02-14 | 2008-08-20 | Polichem S.A. | Use of chitosans for the treatment of nail inflammatory diseases |
US10201490B2 (en) | 2007-02-14 | 2019-02-12 | Polichem Sa | Use of chitosans for the treatment of nail inflammatory diseases |
EP2294126A1 (en) * | 2008-06-11 | 2011-03-16 | Chi2Gel Ltd. | Injectable hydrogel forming chitosan mixtures |
DK2318014T3 (en) * | 2008-07-18 | 2016-12-19 | Genís Hf | New composition for the treatment of autoimmune diseases |
CN102417550B (zh) * | 2010-09-28 | 2014-04-30 | 扬州鸿信生物制品有限公司 | 一种甲壳素生产设备 |
WO2012145626A1 (en) * | 2011-04-22 | 2012-10-26 | Ancora Pharmaceuticals Inc. | Synthetic oligosaccharides for staphylococcus vaccine |
US10130654B2 (en) * | 2011-05-24 | 2018-11-20 | Hangli Biosciences Co., Ltd. | Method of inducing osteogensis and promoting osseointegration around an implant |
GB201205174D0 (en) * | 2012-03-23 | 2012-05-09 | Medtrade Products Ltd | Process for producing low endotoxin chitosan |
MX352422B (es) * | 2012-04-23 | 2017-11-24 | Genis Hf | Composiciones de cemento bioactivas de autoendurecimiento con quitina parcialmente desacetilada como sustitutos de injertos de hueso. |
US20160017062A1 (en) | 2013-03-12 | 2016-01-21 | Wellstat Vaccines, Llc | Antibodies targeted to fungal cell wall polysaccharides |
GB201309607D0 (en) * | 2013-05-29 | 2013-07-10 | Medtrade Products Ltd | Process for producing low endotoxin chitosan |
GB201309606D0 (en) * | 2013-05-29 | 2013-07-10 | Medtrade Products Ltd | Process for producing low endotoxin chitosan |
GB2514592A (en) | 2013-05-30 | 2014-12-03 | Medtrade Products Ltd | Degradable haemostat composition |
FR3016882A1 (fr) | 2014-01-30 | 2015-07-31 | Sofradim Production | Procede de preparation de chitosane a haut degre d’acetylation |
JP6512630B2 (ja) * | 2015-02-26 | 2019-05-15 | オルガノ株式会社 | セレン及び/またはヒ素の濃縮方法及び分析方法並びに装置 |
CN108114321A (zh) * | 2017-12-29 | 2018-06-05 | ***广州总医院 | 一种抗骨巨细胞瘤壳聚糖-纳米羟基磷灰石支架、其制备方法及应用 |
CN109529105A (zh) * | 2018-10-04 | 2019-03-29 | 南京航空航天大学溧水仿生产业研究院有限公司 | 仿生人工骨材料的制备方法 |
WO2020186021A1 (en) * | 2019-03-13 | 2020-09-17 | Virginia Commonwealth University | Method for forming flexible and biodegradable structures from low molecular weight chitin biopolymers |
WO2021195452A1 (en) * | 2020-03-26 | 2021-09-30 | Subhra Mohapatra | Use of oligochitosans and derivatives thereof for neutralizing viral agents |
CN111803714B (zh) * | 2020-07-29 | 2021-12-21 | 陕西科技大学 | 一种综合酸-碱溶剂体系的壳聚糖骨修复支架及其制备方法 |
CN112341551A (zh) * | 2020-11-05 | 2021-02-09 | 广东广纳安疗科技有限公司 | 一种具有超低内毒素的壳聚糖类物质及其制备方法 |
CN112724273B (zh) * | 2021-01-26 | 2022-02-22 | 焦点生物医药有限公司 | 一种高分子量银耳多糖的提取及制备方法 |
EP4122961A1 (en) * | 2021-07-20 | 2023-01-25 | Westfälische Wilhelms-Universität Münster | Chitosan oligomers and uses thereof |
WO2023119335A1 (en) * | 2021-12-20 | 2023-06-29 | Genis Hf. | Implants with bioactive coating comprising partially deacetylated chitosan |
CN114533967B (zh) * | 2022-03-30 | 2023-01-03 | 江苏益通生物科技有限公司 | 一种脱乙酰壳聚糖神经导管及其制备方法 |
WO2024033950A1 (en) * | 2022-08-11 | 2024-02-15 | Genis Hf. | 3d printed bioactive scaffolds |
Family Cites Families (17)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US2795579A (en) * | 1953-10-09 | 1957-06-11 | Warner Lambert Pharmaceutical | Process for purification of chitosan by means of the salicylic acid salt thereof |
HU202252B (en) * | 1988-11-30 | 1991-02-28 | Rhone Poulenc Sante | Process for producing new kitozane derivatives and food additives coated with them |
JP2814701B2 (ja) * | 1990-06-04 | 1998-10-27 | 味の素株式会社 | 水容性部分脱アセチル化キチンの製造法 |
JP3181337B2 (ja) * | 1991-09-13 | 2001-07-03 | ピアス株式会社 | キトサンオリゴ糖混合物の製造方法、及びキチンオリゴ糖混合物の製造方法 |
KR970008132B1 (ko) | 1993-02-08 | 1997-05-21 | 전동원 | 생체 임상의학용 키틴 및 키토산 제조방법 |
JP3118423B2 (ja) * | 1996-08-30 | 2000-12-18 | ツヤック株式会社 | 水溶性の部分アセチル化キトサン液の製造方法 |
JP2990248B2 (ja) * | 1997-06-18 | 1999-12-13 | 鳥取県 | 非晶質の水溶性部分脱アセチル化キチンの製造方法 |
JPH11276189A (ja) * | 1998-03-30 | 1999-10-12 | Tottori Prefecture | 非晶質の水溶性部分脱アセチル化キチンを基質とする酵素によるオリゴ糖の製造方法 |
US20030158302A1 (en) * | 1999-12-09 | 2003-08-21 | Cyric Chaput | Mineral-polymer hybrid composition |
JP3653626B2 (ja) * | 2000-01-13 | 2005-06-02 | 独立行政法人科学技術振興機構 | 有機・無機交互多重積層複合体 |
JP4669932B2 (ja) * | 2000-05-02 | 2011-04-13 | 学校法人日本大学 | 生体材料用組成物及びその硬化体 |
US7014749B2 (en) * | 2000-12-28 | 2006-03-21 | Board Of Regents Of The University Of Nebraska | Electrolytic deposition of coatings for prosthetic metals and alloys |
NO20015986D0 (no) * | 2001-08-02 | 2001-12-06 | Einar J Mustaparta | Produktet chitosan, samt fremstillingsmetode og anvendelse av chitosan |
IS6085A (is) * | 2001-09-26 | 2003-03-27 | Genis Ehf. | Lyfjablanda með kítósan óligómerum |
JP3755004B2 (ja) * | 2003-07-01 | 2006-03-15 | 独立行政法人物質・材料研究機構 | キチン誘導体−リン酸カルシウム複合体繊維とその製造方法 |
CN1233664C (zh) * | 2003-12-23 | 2005-12-28 | 孝感学院 | 一种制备水溶性壳聚糖的方法 |
DE202008005046U1 (de) | 2008-04-11 | 2008-07-03 | Design Ballendat Gmbh | Tisch mit verschwenkbarem Bügelfuß |
-
2006
- 2006-06-14 RU RU2008101385/05A patent/RU2421467C2/ru active
- 2006-06-14 CN CN2006800285048A patent/CN101248019B/zh active Active
- 2006-06-14 AU AU2006257177A patent/AU2006257177A1/en not_active Abandoned
- 2006-06-14 CA CA2611453A patent/CA2611453C/en active Active
- 2006-06-14 NZ NZ565022A patent/NZ565022A/en unknown
- 2006-06-14 SI SI200632196T patent/SI1917218T1/sl unknown
- 2006-06-14 BR BRPI0612034-2A patent/BRPI0612034A2/pt not_active Application Discontinuation
- 2006-06-14 DK DK06745229.2T patent/DK1917218T3/en active
- 2006-06-14 KR KR1020087001087A patent/KR101569751B1/ko active IP Right Grant
- 2006-06-14 WO PCT/IS2006/000013 patent/WO2006134614A1/en active Application Filing
- 2006-06-14 EP EP06745229.2A patent/EP1917218B1/en active Active
- 2006-06-14 JP JP2008516507A patent/JP5632125B2/ja active Active
- 2006-06-14 US US11/922,014 patent/US9078949B2/en active Active
- 2006-06-14 MX MX2007015767A patent/MX336736B/es unknown
- 2006-06-14 HU HUE06745229A patent/HUE035956T2/en unknown
- 2006-06-14 LT LTEP06745229.2T patent/LT1917218T/lt unknown
-
2008
- 2008-01-14 NO NO20080240A patent/NO344086B1/no unknown
-
2014
- 2014-07-10 JP JP2014142045A patent/JP6293005B2/ja active Active
-
2015
- 2015-06-11 US US14/736,984 patent/US20160002360A1/en not_active Abandoned
-
2017
- 2017-12-27 US US15/855,884 patent/US20180186899A1/en not_active Abandoned
-
2019
- 2019-07-30 NO NO20190933A patent/NO20190933A1/no not_active Application Discontinuation
Also Published As
Publication number | Publication date |
---|---|
US20180186899A1 (en) | 2018-07-05 |
RU2421467C2 (ru) | 2011-06-20 |
RU2008101385A (ru) | 2009-07-20 |
HUE035956T2 (en) | 2018-05-28 |
SI1917218T1 (sl) | 2017-12-29 |
EP1917218A1 (en) | 2008-05-07 |
EP1917218B1 (en) | 2017-05-17 |
AU2006257177A1 (en) | 2006-12-21 |
JP5632125B2 (ja) | 2014-11-26 |
WO2006134614A1 (en) | 2006-12-21 |
LT1917218T (lt) | 2017-11-27 |
NO20080240L (no) | 2008-03-06 |
US9078949B2 (en) | 2015-07-14 |
CA2611453A1 (en) | 2006-12-21 |
NO344086B1 (no) | 2019-09-02 |
KR20080036580A (ko) | 2008-04-28 |
CA2611453C (en) | 2015-10-06 |
BRPI0612034A2 (pt) | 2012-08-28 |
US20160002360A1 (en) | 2016-01-07 |
CN101248019B (zh) | 2012-12-26 |
KR101569751B1 (ko) | 2015-11-19 |
JP2014221905A (ja) | 2014-11-27 |
JP6293005B2 (ja) | 2018-03-14 |
NZ565022A (en) | 2011-04-29 |
US20090281058A1 (en) | 2009-11-12 |
DK1917218T3 (en) | 2017-09-11 |
JP2008544014A (ja) | 2008-12-04 |
CN101248019A (zh) | 2008-08-20 |
NO20190933A1 (no) | 2008-03-06 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
MX336736B (es) | Composiciones de derivados de quitina parcialmente desacetilados. | |
Zamboni et al. | On the bacteriostatic activity of hyaluronic acid composite films | |
Venkatesan et al. | Seaweed polysaccharides and their potential biomedical applications | |
Nuttelman et al. | The effect of ethylene glycol methacrylate phosphate in PEG hydrogels on mineralization and viability of encapsulated hMSCs | |
WO2010141133A3 (en) | Silk fibroin systems for antibiotic delivery | |
WO2009005790A3 (en) | Sterile thiol-derivatized hyaluronic acid polymer compositions and uses thereof | |
WO2010123945A3 (en) | Silk fibroin hydrogels and uses thereof | |
BRPI0822625B8 (pt) | dispositivo espaçador modular para o tratamento de infecções por próteses | |
Jiao et al. | Hydrogels based on chitosan in tissue regeneration: How do they work? A mini review | |
GB2483203A (en) | Treatment of acinetobacter with alginate oligomers and antibiotics | |
MY139618A (en) | Biodegradable polyurethane/urea compositions | |
ITMI20101451A1 (it) | Idrogelo a base di acido ialuronico e suo uso in ortopedia | |
ATE504317T1 (de) | Resorbierbares calciumphosphatbasierendes biopolymervernetztes knochenersatzmaterial | |
WO2010023207A3 (en) | Antimicrobial agents | |
WO2011026614A3 (en) | Compositions and methods for disinfecting materials | |
WO2007098114A3 (en) | Clotting and healing compositions containing keratin biomaterials | |
Szymańska et al. | Glycoside hydrolase (PelAh) immobilization prevents Pseudomonas aeruginosa biofilm formation on cellulose-based wound dressing | |
Piątkowski et al. | Microwave-assisted synthesis and characterization of chitosan aerogels doped with Au-NPs for skin regeneration | |
NO20061468L (no) | Anvendelse av tigecyklin, alene eller i kombinasjonmed rifampin for behandling av osteomyelitt og/eller septisk artritt | |
ATE359797T1 (de) | Pharmazeutische zusammensetzung mit chito- oligomeren | |
Bibire et al. | Biopolymers for surgical applications | |
EP2402442A3 (en) | Immunostimulatory properties of oligonucleotide-based compounds comprising modified immunostimulatory dinucleotides | |
RU2010130494A (ru) | Поперечно сшитый гидрогель, содержащий активное соединение | |
Zare et al. | Nanoscience-led antimicrobial surface engineering to prevent infections | |
Joshi et al. | Marine polysaccharides: biomedical and tissue engineering applications |